Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome (NCT05148039) | Clinical Trial Compass
CompletedNot Applicable
Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome
United Kingdom50 participantsStarted 2022-04-07
Plain-language summary
This study involves a comprehensive nutritional assessment of hEDS participants who have functional gastrointestinal disorders and dietary intervention to broaden their food choices and nutritional intake.
Who can participate
Age range16 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have completed Phase I of the CANDI-hEDS study
* Diagnosis of hEDS / HSD according to physical examination and history taking
* Diagnosis of Functional Dyspepsia and / or Irritable Bowel Syndrome according to Rome IV criteria
* Able and willing to give informed consent
* Access to video conferencing and a smart phone device
* Able to travel to the Wingate Institute
Exclusion Criteria:
* Dependent upon artificial feeding (parenteral and enteral)
* Structural gastrointestinal disease
* Any chronic health condition which already requires a restricted diet e.g. diabetes mellitus
* Functional vomiting disorder with associated weight loss
* Multiple Type I hypersensitivity reactions to food groups (i.e. anaphylaxis, urticaria, respiratory symptoms or positive RAST tests).
* Previous or current severe mental health disorder (e.g. severe depression with suicidal ideation)
* Previous or current eating disorder
* Positive screen for avoidant restrictive food intake disorder (ARFID)